A novel strategy in the elimination of disseminated melanoma cells: Chimeric receptors endow T cells with tumor specificity

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 158, Issue , 2001, Pages 249-264

  Abken, H ^a   Hombach, A ^a   Heuser, C ^a   Reinhold, U ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; HYBRID PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANTIBODY SPECIFICITY; HUMAN; IMMUNOLOGY; MELANOMA; PATHOLOGY; REVIEW; T LYMPHOCYTE; TRANSPLANTATION; TUMOR EMBOLISM;

ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MELANOMA; NEOPLASM CIRCULATING CELLS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0035226813     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-59537-0_25     Document Type: Review

References (0)